Topic Archives: Forbes

Comments

  • Link above to the Forbes article is wrong, it goes to a Wired article on Fastly....

  • Found this old piece (May, 2019) in Forbes written by the same Bob Carlson, sounding a much less alarming tone, possibl...

  • It seems he is touting the Blockchain revolution. In particular this is investing in ETF's that invest in various compa...

  • I'm a little surprised to hear that about Bottom Line. My father subscribed to their newsletter. He was a voracious ...

  • in the TEEKA TIWARI’S “GENESIS” video, I thought for sure the first stock was Credit Suisse asset (CIK) because it...

  • Hi Gordie, welcome to our space and thanks for commenting... yes, the promoters often try to add gravitas by including m...

  • Is there an update on the Nasdaq cryptocurrency? The latest thing I've been able to dig up on this was an article by a F...

  • I've never heard of that particular one, but "a cure for every cancer" is exceedingly unlikely. A tiny bit of digging ...

  • Even back in July 2018, Forbes had an article quoting Terry Gou (head of Foxconn) stating that his goal for stock price ...

  • They know more that the business inside and out the ceo was the original ceo of canopy the list of as they refer to it a...

  • I agree with your first comment completely. Forbes I'm not familiar with judging that they are a financial mag and the l...

  • In fact, an article in Forbes magazine states "In reality, the EWG, which has been dubbed the Environmental Worry Group,...

  • Lots of good info from EndPoints: NEW Judgment day is coming: Federal judge orders Martin Shkreli to forfeit a small ...

  • So far all I can find is that after raising $850 billion they decided to have a second private ico round. While they wer...

  • $CWBR#MindBlowing#Thank you Dr. KSS: Excellent Article: Forbes Magazine: "The Cult of DNA-centricity" https://www.for...

  • $NVS, GWPH... $SGYP Needs to raise $25-30m in cash by Jan 31st. Debt covenant shows they need $128m of cash Jan 31s...

  • $ESPR re: today's 10%+ share price decline (ouch) three possible culprits . 1) sharp pullback from a fairly torrid rise...

  • $ONCE, $PFE... NEW http://e.endpointsnews.com/t/ViewEmail/t/09E2A4F6D4C4E999/2F80028A944F69C925D77A725F39070E Park...

  • No experience with customer service, hence voted only on the other items. Best for analysis & quality of writing., w...

  • Travis Good afternoon. Have you looked at Wealthy Retirement touting "Impossible Matter" Found on Jupiter Could Cut Elec...

  • 1 Stock to Buy for the Return of "iPhone Mania" iPhone madness is back. And one little known company is allowing Apple t...

  • $NVS - Was surprised I was the first to post about this, but double-checked and saw the above link from rfyjr. I add...

  • $AUPH HI Denny, just a quick answer to your question. Please be reminded that the ParabolicSAR matrix is a "moving ta...

  • $AUPH's major shareholder: Robert Duggan Featured in Forbes: https://www.forbes.com/profile/robert-duggan/ Best, H...

  • That's an interesting form of prevarication, especially in light of something I read just the other day by a former Forb...

  • you have to watch those money back guarantees. Forbes got me to sign up for one of their investment newsletters. The pre...

  • ABEO with some good ink in Forbes article. This may be one I have to squeeze in portfolio down the road. https://www.fo...

  • Sharon, I have created a .pdf file of the Forbes article, if someone can tell be how to do it, I will upload it or send ...

  • $no ticker. Danmcco, I don't know if its the Forbes website, but I tried various methods to get to the site without su...

  • In my opinion, Weiss has missed many investment returns because they seem to favor Conservative Republicans when histor...

  • $AKAO $AKBA An interesting article from Forbes, just in: "Four stocks moving both on the news and the charts" ...

  • $BIOC - This may be a new Forbes article, but the news goes back to last year and has been commented on here in the past...

  • Do you ever wonder how all those politicians arrive in Washington with "regular" wealth, earn $174,000 a year for a few ...

  • $SCYX (long) Great article, Doc - and very timely. The controversial clinical hold action in this case exemplifies t...

  • https://www.axios.com/business-media-has-its-own-fake-news-problem-2353912512.html Many already know this, but for th...

  • Interesting Article in Forbes tonight about Amgen and ESPR mentioned. Here the link https://www.forbes.com/sites/davidg...

  • $ESPR: Basically, all the arguments in the articles I read today (NEJM, Forbes, IBD et all.) were alluded to in my fir...

  • $ESPR New Forbes article on this subject, just in: "Amgen drug prevents heart attacks, not deaths, disappointing e...

  • Thank YOU for the kind comments, Tony. While Twitter is very speedy, you are correct that the noise-to-signal (sic) r...

  • A Complete Beginner's Guide To #Blockchain via @forbes http://www.forbes.com/sites/bernardmarr/2017/01/24/a-complete-b...

  • Hi Cleveland, Can you research $CYDY finances, will they have to raise equity before completion of HIV Tx. Pro140 Phase...

  • Related to this, an interesting proposal out of Forbes today advocating for the U.S government to buy Gilead to the tune...

  • Seems our little AUPH made the Forbes Dean's list for 2017 as a big idea. Great ink for them because Forbes reach's a lo...

  • Once again thanks for your candor and thoroughness. The Forbes Billionaire Portfolio ad was enticing, but aren't they al...

  • Does anyone have experience with Forbes Billionaire Portfolio newsletter. Sounds intriguing but don't they all!...

  • I've been tuning in to updates from the Forbes 2016 Healthcare Summit in the hope many of the big players attending woul...

  • Came across this in Forbes on gold. What's a person to do? Check out this link on gold http://www.forbes.com/sites/johnw...

  • Here is a Forbes article to illustrate my point: http://www.forbes.com/sites/wallaceforbes/2015/04/28/6-smid-caps-wit...

  • Forbes: Innovative Companies: http://www.forbes.com/innovative-companies/#79707158f172...

  • $ESPR, $AMGN, $SNY, $PFE New Atherosclerosis Study Results Bode Well For PCSK-9 Cholesterol-Lowering Drugs John LaMa...

  • PTLA, KITE, BLUE, INCY mentioned in this Forbes article as possible take over candidates. http://www.forbes.com/sites...

  • Travis Off topic. I don't know how to submit this for your perusal, so am posting it here in case you want to do a tea...

  • Travis, I am one of Jim Rickards' subscribers so I can tell you that his "World Money" play is actually something you w...

  • Forbes was writing about "Deep Learning And Machine Intelligence " in an article dating to 2014. http://www.forbes.com/s...

  • Here is discussion which includes a Forbes article and links describing ETC, ETH, the hard fork and Kraken. http://ww...

  • http://www.forbes.com/sites/anthonykosner/2014/12/29/tech-2015-deep-learning-and-machine-intelligence-will-eat-the-world...

  • $ESPR http://www.esperion.com/note-from-our-ceo/ This is Tim Mayleben – CEO of Esperion Therapeutics with some tho...

  • Juno: ''Remarkably, Juno gave the news about the hold to Forbes writers ahead of the announcement.'' That sounds like tr...

  • How Deep Learning Networks Can Use Virtual Worlds To Solve Real World Problems - Forbes http://buff.ly/1Nl23dW #ai htt...

  • How Deep Learning Networks Can Use Virtual Worlds To Solve Real World Problems - Forbes http://buff.ly/1Nl23dW #ai...

  • Will leave comment on this article to the experts here, but interestingly did just read this article from Forbes on fili...

  • Forbes article on how GILD can double in 3 years. http://www.forbes.com/sites/kenkam/2016/04/15/gild-future-biotech-fun...

  • From Forbes -- the largest biotech you never heard of... http://www.forbes.com/sites/matthewherper/2016/04/13/the-god-p...

  • Travis 2.1 billion Zuckerburg is NVDA tease based Zucks investment in Virtual Reality. Forbes just released their ann...

  • Forbes article with ESPR mentioned. http://www.forbes.com/sites/matthewherper/2016/04/03/some-people-really-cant-take...

  • No, he really did mean Unum Therapeutics. It's a private CAR-T variant play that has been financed by venture capitalist...

  • Forbes Names Cannabis CEO to Prominent List: http://mjbizdaily.com/forbes-names-cannabis-ceo-to-prominent-list/ Best2A...

  • In July 2015, Forbes reported on twitter, "It’s safe to say that cloud computing is the next “big thing.” http...

  • Back to the title article, from Forbes we get: Want to Fight a Deadly Fungus? San Diego's Amplyx Just Got $41M For That...

  • That Forbes list link led to only five stocks, and the timeline under each was for 2011. Heartland Payment Systems HPY ...

  • Investors have lost literally hundreds of thousands getting into such "ground-floor" companies. Without understanding wh...

  • GILD mentioned as blue chip bargain by Forbes. http://forbesmags.com/slp/blue_chip_oct15.pdf Cheers,Glenn...

  • The Future Of Medicine -- Where Investors Are Putting Their Money: http://www.forbes.com/sites/realspin/2015/05/01/the-...

  • Glenn: I came across that article too, it's pretty lame--he has a cursory at best knowledge of these companies, but it's...

  • Forgot to mention PTLA was mentioned in Forbes article as well. Cheers,Glenn...

  • ZFGN and ESPR mentioned in Forbes article. http://www.forbes.com/sites/greatspeculations/2015/10/09/biogen-and-four-oth...

  • $ESPR Forbes Pharma & Healthcare Amgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will ...

  • Forbes Pharma & Healthcare - David Sable, Contributor Five Reasons Why Your Biotech Comparative Value Theory Is Wrong ...

  • From John LaMattina @ Forbes: Will Alnylam's New PCSK-9 Cholesterol Lowering Drug Be A Blockbuster? "before christen...

  • Interesting article in Forbes: When Doctors Invest: Dumb Mistakes And Offsetting Advantages By David Sable , Contrib...

  • The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles John LaMattina , Contributor I cover news on d...

  • Interesting Forbes article on NDA's and approvals. http://www.forbes.com/sites/matthewherper/2015/08/25/nine-explanatio...

  • Forbes on PTN -- take your profit and run: http://www.forbes.com/sites/johnlamattina/2015/08/18/you-can-call-it-the-fem...

  • Forbes point of view on patient death in KITE trial. http://www.forbes.com/sites/matthewherper/2015/08/17/patient-death...

  • Just watched the Theranos TED talk yesterday--most interesting It is private company. They have already raised $400 m...

  • Read an article in my Forbes magazine, Issue July 20 regarding Docker. Assume that is the business you are referring ...

  • Forbes view on JUNO/CELGENE deal. http://www.forbes.com/sites/stephenbrozak/2015/06/30/did-celgenes-billion-dollar-deal...

  • ESPR This from Forbes (not that positive about Esperion) Why Esperion Shares Are Down 18% Today Shares of Esper...

  • I see this Forbes article from Matt saying $ESPR needs to worry since they may need large trials. http://www.forbes.c...

  • Interesting and very public battle going on about this drug, and the issues are at least as much politics and perception...

  • There's only a fixed number of services that they remarket over and over with different copywriting. Occasionally they ...

  • Forbes Biotech report. http://www.forbes.com/sites/luketimmerman/2015/05/23/what-you-may-have-missed-in-biotech-eye-dru...

  • ESPR Chardan managed to get lame hit piece into Forbes: http://blogs.barrons.com/stockstowatchtoday/2015/05/22/esperio...

  • $LNEGY Siluria (wi) news article 10 days ago in Forbes sez Paul Allen of Vulcan Capital is now in Siluria and they i...

  • Great story written today at Forbes on Immune system combo drugs to fight cancer. http://www.forbes.com/sites/matthewhe...

  • If you haven't seen the currently running 3-part Cancer series on PBS, I recommend you catch it. Part 2 tonight and p3 t...

  • I find excellent information with Forbes as they discuss everything from current to future companies moving forward and ...

  • No, it is real, and serious. What I hate are disgruntled pompous Trotskyite arses like Matthew Herper whining on Forbes ...

  • ( ACT, CELG , GILD, NOV) Matthew Herper , Forbes Staff reporter has ranked the large pharmacopoeias. .Top Of The C...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info